Metenolone Enanthate is an injectable anabolic-androgenic steroid (AAS) belonging to the dihydrotestosterone (DHT) group. Metenolone Enanthate is also known as primobolan. This drug is a single long acting ester steroid. It is one of the mildest anabolic steroids available in the market. Methenelone is low in androgen levels. This drug is used to promote weight gain following extensive surgery, severe trauma, chronic infection, and in other cases that result in inadequate weight gain or maintenance.

Market Analysis and Insights: Global Metenolone Enanthate Market
The global Metenolone Enanthate market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Metenolone Enanthate Scope and Market Size
The global Metenolone Enanthate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metenolone Enanthate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Oral
Injectable

Segment by Application
Bodybuilding
Sports
Surgery
Others

The Metenolone Enanthate market is analysed and market size information is provided by regions (countries). Segment by Application, the Metenolone Enanthate market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Dragon Pharmaceuticals Inc.
Wellona Pharma
Geneza Pharmaceuticals
Kosher Pharmaceuticals
British Dragon Pharmaceuticals
International Pharmaceuticals